Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman aged 18 or older
- You have been recently diagnosed with a type of cervical cancer called squamous cell carcinoma that has not been treated before
- Your cancer is locally advanced (at a certain stage of spread within the pelvic area) but has not spread to distant parts of the body
- You are generally in good health and able to carry out daily activities, with no major organ problems
- You are willing and able to give your written agreement to take part in the trial
Who may not be able to join:
- You have a history of a condition that weakens your immune system
- You have any health condition that the research team feels could put you at higher risk from the treatment (confirm with trial site)
- You have previously received, or are currently receiving, a type of cancer treatment called a PD-1 or PD-L1 immunotherapy (a specific kind of treatment that uses the immune system to fight cancer)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Haoping Xu, Ruijin Hospital
Phone: 8618801970632
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
2-year progression-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.